Evidence map›Paper›PMID 29739437›Full record

ArticleBMC research notes2018

Induction of the acid inducible lipF promoter is reversibly inhibited in pH ranges of pH 4.2-4.0.

Rachelle Torres, Donna Dorriz, Beatrice Saviola

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rachelle TorresMercy Medical Center Merced Hospital, 333 Mercy Avenue, Merced, CA, 95340, USA.
Donna DorrizBasic Medical Sciences, College of Osteopathic Medicine, Western University of Health Sciences, 309 E. Second St., Pomona, CA, 91766, USA.
Beatrice SaviolaBasic Medical Sciences, College of Osteopathic Medicine, Western University of Health Sciences, 309 E. Second St., Pomona, CA, 91766, USA. bsaviola@westernu.edu.ORCID http://orcid.org/0000-0001-9923-2546
Western University of Health Sciences · USMercy Medical Center Merced · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn the human body pathogenic mycobacteria encounter low pH within the phagosomes of macrophages where they reside after being internalized by the host cell. Low pH within macrophages has been shown to induce expression of a variety of genes within these bacteria. It had been previously observed that the Mycobacterium tuberculosis lipF promoter is transcriptionally upregulated between pHs 4.5-6.4 in Mycobacterium smegmatis, with an upper pH limit of 6.4 capable of promoter induction. To better understand the parameters of acid induced gene expression, we sought to determine the lower pH limit capable of lipF promoter induction.

resultsAs we had already determined an upper pH limit, we determine here that there is a lower limit of pH's capable of upregulating the lipF promoter, with pH below 4.3 not positively upregulating the promoter. At non-inducing pH 4.2 the bacterial cells remain viable in the absence of acid induced lipF promoter upregulation and subsequent exposure to acid pH 5.0 results in lipF promoter upregulation. There appears to be a lower limit of pH capable of upregulating lipF promoter expression and this limit is not due to cell death.

Indexed as

Promoter Regions, GeneticAcidsBacterial ProteinsEscherichia coliGene Expression Regulation, BacterialHydrogen-Ion ConcentrationMycobacterium smegmatisAcidsBacterial ProteinsAcidic stressLipaselipFMycobacterium tuberculosis

Identifiers

PMID29739437
PMCPMC5941605
OpenAlexW2805906426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.